Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

36.00
Delayed Data
As of 4:00pm ET
 +0.55 / +1.55%
Today’s Change
26.95
Today|||52-Week Range
52.48
-21.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues69.3M70.9M67.3M79.1M
 
 
 
 
 
Cost of Goods Sold21.5M20.1M14.9M17.6M
 
 
 
 
 
Depreciation And Amortization3.1M3.7M3.4M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income44.7M47.1M49.1M57.8M
 
 
 
 
 
General Expenses58.8M58.4M52.4M49.2M
 
 
 
 
 
Research And Development16.6M18.9M11.8M10.0M
 
 
 
 
 
Total Operating Expenses83.3M82.2M70.6M70.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.1M-11.3M-3.3M8.6M
 
 
 
 
 
Extraordinary Charge-3.7M-4.5M-260.0K-113.0K
 
 
 
 
 
Interest Expense On Debt2.8M5.4M5.4M5.5M
 
 
 
 
 
Other Expenses10.0K80.0K79.0K-2.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.8M-19.7M-7.6M4.6M
 
 
 
 
 
Income Taxes-30.0K-30.0K-45.0K-35.0K
 
 
 
 
 
Net Income-19.9M-19.7M-7.6M4.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS38.0M40.2M40.5M40.6M
 
 
 
 
 
Shares To Calculate EPS Diluted38.0M40.2M40.5M41.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.52-$0.49-$0.19$0.11
 
 
 
 
 
EPS Diluted-$0.52-$0.49-$0.19$0.11